Dr Niceto Lopez, MD - Medicare Internal Medicine in Walnut Creek, CA

Dr Niceto Lopez, MD is a medicare enrolled "Hospitalist" physician in Walnut Creek, California. He graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as Internal Medicine. His current practice location is 801 Ygnacio Valley Rd, Suite 250, Walnut Creek, California. You can reach out to his office (for appointments etc.) via phone at (925) 946-1080.

Dr Niceto Lopez is licensed to practice in California (license number A96421) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003012931.

Contact Information

Dr Niceto Lopez, MD
801 Ygnacio Valley Rd, Suite 250,
Walnut Creek, CA 94596-3871
(925) 946-1080
Not Available



Physician's Profile

Full NameDr Niceto Lopez
GenderMale
SpecialityInternal Medicine
Experience23 Years
Location801 Ygnacio Valley Rd, Walnut Creek, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Niceto Lopez graduated from medical school in 2001
  NPI Data:
  • NPI Number: 1003012931
  • Provider Enumeration Date: 06/26/2007
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 3577651264
  • Enrollment ID: I20071113000785

Medical Identifiers

Medical identifiers for Dr Niceto Lopez such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003012931NPI-NPPES
A96421OtherCAMECIAL LICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist A96421 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Brentwood Health Care CenterSanta monica, CANursing home
Country Villa East Nursing CenterLos angeles, CANursing home
Lynwood Healthcare CenterLynwood, CANursing home
Fireside Health Care CenterSanta monica, CANursing home
La Brea Rehabilitation CenterLos angeles, CANursing home

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Niceto Lopez allows following entities to bill medicare on his behalf.
Entity NameJohn Muir Physician Network
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841407665
PECOS PAC ID: 6608789813
Enrollment ID: O20031226000143

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NameEast Bay Hospitalists, A Medical Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568487429
PECOS PAC ID: 7113919788
Enrollment ID: O20040401001616

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NameJohn Muir Trauma Physicians Billing Service
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093864837
PECOS PAC ID: 3476542515
Enrollment ID: O20050420001452

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NamePalliative Care Doctors Group, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578826053
PECOS PAC ID: 6305092768
Enrollment ID: O20120820000105

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NameKansal Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043510183
PECOS PAC ID: 6406089739
Enrollment ID: O20140512001295

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NameProvidence Saint Johns Medical Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1518438712
PECOS PAC ID: 0840548624
Enrollment ID: O20180810000904

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Entity NameNiceto Lopez M.d. A.p.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710518881
PECOS PAC ID: 0648609321
Enrollment ID: O20200331002942

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Niceto Lopez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Niceto Lopez, MD
3608 Lakeshore Ave Apt 3,
Oakland, CA 94610-1763

Ph: (510) 444-4589
Dr Niceto Lopez, MD
801 Ygnacio Valley Rd, Suite 250,
Walnut Creek, CA 94596-3871

Ph: (925) 946-1080

News Archive

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

Study predicts dramatic growth in cancer rates among US elderly, minorities

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

EUREKA's decision-makers approves promising cooperative R&D projects

Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.

Counting immune cells on a 'protein printboard'

In order to monitor how far an HIV infection has progressed, the number of immune cells - lymphocytes - must be counted. Researchers at the University of Twente have developed a method that neatly arranges the antibodies that bind to these immune cells on a 'molecular printboard'. The researchers are publishing this key step in the road towards antibody-based sensors in the Journal of the American Chemical Society (JACS).

Read more News

› Verified 4 days ago


Hospitalist Doctors in Walnut Creek, CA

Dr. Thomas Cresante, D.O.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1425 S Main St, Kaiser Permanente Walnut Creek Attn: Hbs Dept, Walnut Creek, CA 94596
Phone: 925-295-4643    
Maria L. Domantay, MD
Hospitalist
Medicare: Not Enrolled in Medicare
Practice Location: 1425 S Main St, Walnut Creek, CA 94596
Phone: 925-295-4000    
Tsao-yu Liang, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1425 S Main St, Walnut Creek, CA 94596
Phone: 925-295-4000    
Rujuta J. Manghani, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1450 Treat Blvd, Ste 160, Walnut Creek, CA 94597
Phone: 925-296-9000    
Timothy P. Corfman, MD
Hospitalist
Medicare: Not Enrolled in Medicare
Practice Location: 1425 S Main St, Walnut Creek, CA 94596
Phone: 925-295-4000    
John Y. Kim, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1425 S Main St, Walnut Creek, CA 94596
Phone: 925-295-4000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.